Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
Saved in:
| Title: | Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature. |
|---|---|
| Authors: | Duijster JW; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Lieber T; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Pacelli S; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.; School of Pharmacy, Biotechnology, and Sport Sciences, University of Bologna, Bologna, Italy., Van Balveren L; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Ruijs LS; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Raethke M; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Kant A; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Jan 30; Vol. 14, pp. 1078736. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023). |
| Publication Type: | Review; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36793715 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Duijster+JW%22">Duijster JW</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Lieber+T%22">Lieber T</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Pacelli+S%22">Pacelli S</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.; School of Pharmacy, Biotechnology, and Sport Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Van+Balveren+L%22">Van Balveren L</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Ruijs+LS%22">Ruijs LS</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Raethke+M%22">Raethke M</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kant+A%22">Kant A</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+Hunsel+F%22">Van Hunsel F</searchLink>; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Jan 30; Vol. 14, pp. 1078736. <i>Date of Electronic Publication: </i>2023 Jan 30 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Review; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36793715 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1078736 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1078736 Titles: – TitleFull: Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Duijster JW – PersonEntity: Name: NameFull: Lieber T – PersonEntity: Name: NameFull: Pacelli S – PersonEntity: Name: NameFull: Van Balveren L – PersonEntity: Name: NameFull: Ruijs LS – PersonEntity: Name: NameFull: Raethke M – PersonEntity: Name: NameFull: Kant A – PersonEntity: Name: NameFull: Van Hunsel F IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 01 Text: 2023 Jan 30 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |